These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 27779422)

  • 1. Endogenous Protease Inhibitors in Airway Epithelial Cells Contribute to Eosinophilic Chronic Rhinosinusitis.
    Kouzaki H; Matsumoto K; Kikuoka H; Kato T; Tojima I; Shimizu S; Kita H; Shimizu T
    Am J Respir Crit Care Med; 2017 Mar; 195(6):737-747. PubMed ID: 27779422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis.
    Nagarkar DR; Poposki JA; Tan BK; Comeau MR; Peters AT; Hulse KE; Suh LA; Norton J; Harris KE; Grammer LC; Chandra RK; Conley DB; Kern RC; Schleimer RP; Kato A
    J Allergy Clin Immunol; 2013 Sep; 132(3):593-600.e12. PubMed ID: 23688414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial genes in chronic rhinosinusitis with and without nasal polyps.
    Richer SL; Truong-Tran AQ; Conley DB; Carter R; Vermylen D; Grammer LC; Peters AT; Chandra RK; Harris KE; Kern RC; Schleimer RP
    Am J Rhinol; 2008; 22(3):228-34. PubMed ID: 18588753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low SPINK5 expression in chronic rhinosinusitis.
    Fruth K; Goebel G; Koutsimpelas D; Gosepath J; Schmidtmann I; Mann WJ; Brieger J
    Laryngoscope; 2012 Jun; 122(6):1198-204. PubMed ID: 22570283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical severity and epithelial endotypes in chronic rhinosinusitis.
    Lam M; Hull L; McLachlan R; Snidvongs K; Chin D; Pratt E; Kalish L; Sacks R; Earls P; Sewell W; Harvey RJ
    Int Forum Allergy Rhinol; 2013 Feb; 3(2):121-8. PubMed ID: 23038685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heme oxygenase-1 expression in chronic rhinosinusitis with eosinophilic infiltration.
    Kawano K; Kusunoki T; Ono N; Yao T; Saito T; Yokoi H; Ikeda K
    Auris Nasus Larynx; 2012 Aug; 39(4):387-92. PubMed ID: 22078849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-33 Expression in Chronic Rhinosinusitis with Nasal Polyps and Its Relationship with Clinical Severity.
    Song W; Wang C; Zhou J; Pan S; Lin S
    ORL J Otorhinolaryngol Relat Spec; 2017; 79(6):323-330. PubMed ID: 29186722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of IFN-γ, IL-13, and IL-17 on mucociliary differentiation of nasal epithelial cells in chronic rhinosinusitis with nasal polyps.
    Jiao J; Duan S; Meng N; Li Y; Fan E; Zhang L
    Clin Exp Allergy; 2016 Mar; 46(3):449-60. PubMed ID: 26399381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-25 and interleukin-33 as mediators of eosinophilic inflammation in chronic rhinosinusitis.
    Lam M; Hull L; Imrie A; Snidvongs K; Chin D; Pratt E; Kalish L; Sacks R; Earls P; Sewell W; Harvey RJ
    Am J Rhinol Allergy; 2015; 29(3):175-81. PubMed ID: 25975248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased exhaled nitric oxide and its oxidation metabolism in eosinophilic chronic rhinosinusitis.
    Takeno S; Taruya T; Ueda T; Noda N; Hirakawa K
    Auris Nasus Larynx; 2013 Oct; 40(5):458-64. PubMed ID: 23489830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged allergen exposure is associated with increased thymic stromal lymphopoietin expression and Th2-skewing in mouse models of chronic rhinosinusitis.
    Kim DW; Eun KM; Jin HR; Cho SH; Kim DK
    Laryngoscope; 2016 Aug; 126(8):E265-72. PubMed ID: 27107152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of the epithelial anion transporter pendrin/SLC26A4 in nasal polyps of patients with chronic rhinosinusitis.
    Seshadri S; Lu X; Purkey MR; Homma T; Choi AW; Carter R; Suh L; Norton J; Harris KE; Conley DB; Kato A; Avila PC; Czarnocka B; Kopp PA; Peters AT; Grammer LC; Chandra RK; Tan BK; Liu Z; Kern RC; Schleimer RP
    J Allergy Clin Immunol; 2015 Dec; 136(6):1548-1558.e7. PubMed ID: 26143180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of calprotectin on TSLP and IL-25 production from airway epithelial cells.
    Kato T; Kouzaki H; Matsumoto K; Hosoi J; Shimizu T
    Allergol Int; 2017 Apr; 66(2):281-289. PubMed ID: 27475624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antimicrobial protein short palate, lung, and nasal epithelium clone 1 (SPLUNC1) is differentially modulated in eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps.
    Wei Y; Xia W; Ye X; Fan Y; Shi J; Wen W; Yang P; Li H;
    J Allergy Clin Immunol; 2014 Feb; 133(2):420-8. PubMed ID: 24342548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional expression of epithelial MDR1/P-glycoprotein in chronic rhinosinusitis with and without nasal polyposis.
    Bleier BS
    Int Forum Allergy Rhinol; 2012; 2(2):122-5. PubMed ID: 22223515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAR-2 activation regulates IL-8 and GRO-alpha synthesis by NF-kappaB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epithelium.
    Rudack C; Steinhoff M; Mooren F; Buddenkotte J; Becker K; von Eiff C; Sachse F
    Clin Exp Allergy; 2007 Jul; 37(7):1009-22. PubMed ID: 17581194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cystatin SN is an endogenous protease inhibitor that prevents allergic rhinitis.
    Fukuoka A; Matsushita K; Morikawa T; Adachi T; Yasuda K; Kiyonari H; Fujieda S; Yoshimoto T
    J Allergy Clin Immunol; 2019 Mar; 143(3):1153-1162.e12. PubMed ID: 30012514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSLP regulates eotaxin-1 production by nasal epithelial cells from patients with eosinophilic CRSwNP.
    Wang WW; Lu DM; Zheng M; Zhang JG; Zhang B
    Rhinology; 2018 Dec; 56(4):370-377. PubMed ID: 29911210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation and expression of IL-32 in chronic rhinosinusitis.
    Soyka MB; Treis A; Eiwegger T; Menz G; Zhang S; Holzmann D; Akdis CA; Meyer N
    Allergy; 2012 Jun; 67(6):790-8. PubMed ID: 22486709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease.
    Pothoven KL; Norton JE; Hulse KE; Suh LA; Carter RG; Rocci E; Harris KE; Shintani-Smith S; Conley DB; Chandra RK; Liu MC; Kato A; Gonsalves N; Grammer LC; Peters AT; Kern RC; Bryce PJ; Tan BK; Schleimer RP
    J Allergy Clin Immunol; 2015 Sep; 136(3):737-746.e4. PubMed ID: 25840724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.